This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Asia Bio Partnering Forum
Marina Bay Sands Convention Center
April 24—25, 2024 | SingaporeApril 29—30, 2024 | Virtual

Matthew Sheroff
Head of New Business Development at Janssen Asia Pacific


Matt Sheroff and his team lead the evaluation process for regional business cases for mid- and late-stage assets for both regional and global business development (BD) opportunities, as well as supporting the ongoing life cycle management activities for Janssen’s established products portfolio.

Prior to joining Janssen Asia Pacific, Matt was Director of Oncology Transactions as part of the Janssen Business Team, with responsibility for leading the execution of clinical trial agreements, supply agreements and collaborations with industry partners, supporting external transactions, driving the development of BD strategies and tactics, and performing ad-hoc strategic analysis in support of the Oncology portfolio. 

Prior to joining the Janssen Business Development team, Matt was a member of the BD Finance team supporting several key transactions for the Oncology and ID&V therapeutic areas; and also spent several years supporting the Johnson & Johnson Vision Care Business in the US with roles in Finance, Supply Chain and Sales Reporting.

Matt is a graduate of Penn State University with a Bachelor’s degree in Finance.  He began his career at Johnson & Johnson in 2010 as part of the Financial Leadership Development Program. 

Agenda Sessions

  • Asia Bio Partnering Forum Workshop Session 1: Out-Bound Deals - What is Sought after, and How to Get a Deal Done?